Advertisement
Advertisement
CTSO
Cytosorbents Corp.
0.61
USDSponsored
0.00
-0.08%
May 08, 15:29 UTC -4
Closed
After-Market
0.60
0.00
-0.66%
CTSO Earnings Reports
Positive Surprise Ratio
CTSO beat 21 of 41 last estimates.
51%
Next Report
In 3 Days
Date of Next Report
May 13, 2026
Estimate for Q1 26 (Revenue/ EPS)
$9.55M
/-$0.05
Implied change from Q4 25 (Revenue/ EPS)
+3.42%
/-44.44%
Implied change from Q1 25 (Revenue/ EPS)
+9.43%
/+150.00%
Cytosorbents Corp. earnings per share and revenue
On Mar 25, 2026, CTSO reported earnings of -0.09 USD per share (EPS) for Q4 25, missing the estimate of -0.05 USD, resulting in a -76.47% surprise. Revenue reached 9.23 million, compared to an expected 9.78 million, with a -5.57% difference. The market reacted with a +4.11% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 4 analysts forecast an EPS of -0.05 USD, with revenue projected to reach 9.55 million USD, implying an decrease of -44.44% EPS, and increase of 3.42% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Rockwell Medical, Inc. (DE) Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.02
Actual
-$0.04
Surprise
-56.86%
Nephros Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.01
Actual
$0.01
Surprise
-1.96%
Myomo Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.11
Actual
-$0.09
Surprise
+21.81%
Lantheus Holdings, Inc
Report Date
May 07, 2026 For Q1 26
Estimate
$1.26
Actual
$1.46
Surprise
+15.85%
ICU Medical Inc
Report Date
May 07, 2026 For Q1 26
Estimate
$1.78
Actual
$1.97
Surprise
+10.26%
Haemonetics Corporation
Report Date
May 07, 2026 For Q4 26
Estimate
$1.28
Actual
$1.29
Surprise
+0.42%
BioLife Solutions Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.02
Actual
$0.04
Surprise
+96.08%
Maravai LifeSciences Holdings, Inc. Class A Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.04
Actual
$0.01
Surprise
+120.79%
Varex Imaging Corporation Common Stock
Report Date
May 07, 2026 For Q2 26
Estimate
$0.21
Actual
$0.21
Surprise
-1.82%
InfuSystem Holdings, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.03
Actual
$0.05
Surprise
+46.63%
FAQ
What were Cytosorbents Corp.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Cytosorbents Corp. reported EPS of -$0.09, missing estimates by -76.47%, and revenue of $9.23M, -5.57% below expectations.
How did the market react to Cytosorbents Corp.'s Q4 2025 earnings?
The stock price moved up 4.11%, changed from $0.70 before the earnings release to $0.73 the day after.
When is Cytosorbents Corp. expected to report next?
The next earning report is scheduled for May 13, 2026.
What are the forecasts for Cytosorbents Corp.'s next earnings report?
Based on 4
analysts, Cytosorbents Corp. is expected to report EPS of -$0.05 and revenue of $9.55M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement